We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXLS icon
1
EXL Service
EXLS
$4.36B
$830K 0.42%
19,549
+1,825
+10% +$74.6K
DK icon
2
Delek US
DK
$3.95B
$724K 0.37%
+24,407
New +$871K
FVRR icon
3
Fiverr
FVRR
$398M
$704K 0.36%
35,626
+18,338
+106% +$395K
ASAN icon
4
Asana
ASAN
$1.79B
$674K 0.34%
49,191
+32,877
+202% +$452K
AVGO icon
5
Broadcom
AVGO
$1.82T
$669K 0.34%
+1,932
New +$691K
ITRI icon
6
Itron
ITRI
$3.76B
$666K 0.34%
7,172
+4,537
+172% +$494K
EAT icon
7
Brinker International
EAT
$8.38B
$649K 0.33%
4,520
+902
+25% +$118K
HLF icon
8
Herbalife
HLF
$1.26B
$643K 0.33%
49,915
-7,405
-13% -$78.4K
NVDA icon
9
NVIDIA
NVDA
$4.76T
$631K 0.32%
3,385
+1,155
+52% +$215K
EVLV icon
10
Evolv Technologies
EVLV
$980M
$630K 0.32%
88,022
+15,798
+22% +$112K
LVS icon
11
Las Vegas Sands
LVS
$31.6B
$630K 0.32%
9,682
+2,920
+43% +$179K
VICI icon
12
VICI Properties
VICI
$29.5B
$629K 0.32%
22,362
+7,212
+48% +$214K
CENX icon
13
Century Aluminum
CENX
$4.44B
$628K 0.32%
16,022
+6,143
+62% +$192K
A icon
14
Agilent Technologies
A
$38.9B
$616K 0.31%
+4,524
New +$650K
MTN icon
15
Vail Resorts
MTN
$5.28B
$597K 0.3%
4,497
+2,896
+181% +$426K
BSX icon
16
Boston Scientific
BSX
$67.6B
$595K 0.3%
6,244
+766
+14% +$75.1K
WMG icon
17
Warner Music
WMG
$14.4B
$594K 0.3%
+19,355
New +$591K
WMT icon
18
Walmart Inc
WMT
$889B
$574K 0.29%
5,150
+3,180
+161% +$341K
RUN icon
19
Sunrun
RUN
$2.38B
$572K 0.29%
31,102
+11,403
+58% +$219K
BTU icon
20
Peabody Energy
BTU
$2.81B
$571K 0.29%
+19,229
New +$565K
GD icon
21
General Dynamics
GD
$105B
$566K 0.29%
+1,680
New +$573K
NIO icon
22
NIO
NIO
$11.6B
$564K 0.29%
110,544
+90,212
+444% +$557K
REAL icon
23
The RealReal
REAL
$1.4B
$563K 0.28%
+35,668
New +$466K
AWI icon
24
Armstrong World Industries
AWI
$7.05B
$541K 0.27%
+2,833
New +$541K
ECHO
25
EchoStar
ECHO
$25.1B
$540K 0.27%
+4,970
New +$405K
1
2 3 4 5

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
AIA
Acute Investment Advisory Mesa, Arizona $8.91M AUM 4.28% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.